Search results
Singapore. At GSK, we unite science, technology and talent to get ahead of disease together. We prevent and treat disease with vaccines, specialty and general medicines investing in four core therapeutic areas: infectious diseases, HIV, respiratory/immunology, and oncology.
Jul 13, 2023 · SINGAPORE - The expansion of British drugmaker GSK’s facility in Tuas has earned the title of Singapore’s largest vaccine production site based on a cumulative investment of some $850 million,...
Jul 13, 2023 · THE expansion of British drugmaker GSK’s facility at Tuas has earned it the title of Singapore’s largest vaccine production site based on a cumulative investment of some S$850 million, said Minister for Trade and Industry Gan Kim Yong.
Nov 17, 2022 · SINGAPORE - GSK officially opened its first high-potency manufacturing and test facility in Singapore on Thursday, with the capability to manufacture highly potent components for cancer...
Nov 17, 2022 · Facility will manufacture a key ingredient for antibody drug conjugates (ADCs) GSK plc today announced the opening of a new, S$44 million high potency facility (HPF) in its strategic New Product Introduction site in Jurong, Singapore.
Issued: 17 November 2022, Singapore GSK opens first-in-Singapore high potency manufacturing and testing facility for next generation cancer treatments • S$44m investment in the new high potency manufacturing facility and laboratory further strengthens Jurong site capabilities to launch new products more quickly
Jul 13, 2023 · Global biopharmaceutical powerhouse GSK is expanding its Tuas vaccines facility in Singapore and will begin producing drug substances for Hepatitis B vaccines when commercial production commences in 2027.
GSK’s latest investment is a strong show of confidence in Singapore’s world-class infrastructure and skilled workforce for biopharmaceutical manufacturing. In addition to efforts in developing manufacturing leaders in Singapore, GSK has also been a steadfast partner to our research ecosystem.
GSK - Global Network. The wide range of Electronics components at the Good price and Best service. IPO Division. IPO DIVISION is dedicated to provide customers with efficient component outsourcing, through an extensive network of Manufacturers and Suppliers. Read More. GSK 15th Years Anniversary. More VDO. News Update. GSK Chemical In Product (CIP)
Nov 17, 2022 · GSK continues to grow its manufacturing footprint in Singapore with the opening of a new 44 million Singapore dollar ($33 million) (PDF) plant that will be focused on producing key ingredients...
